Clinical Trial Update: A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SUN101 (EP-101) for efficacy and safety in moderate-to-severe chronic obstructive pulmonary disease has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SUN101 (EP-101)

Snippet

Sponsor: Sunovion Respiratory Development Inc. | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2018-03-08